4D Molecular Therapeutics, Inc. (NASDAQ:FDMT) CEO David Kirn Sells 12,930 Shares
4D Molecular Therapeutics, Inc. (NASDAQ:FDMT – Get Free Report) CEO David Kirn sold 12,930 shares of the business’s stock in a transaction dated Monday, June...
DA Davidson Reaffirms “Buy” Rating for AAON (NASDAQ:AAON)
DA Davidson reissued their buy rating on shares of AAON (NASDAQ:AAON – Free Report) in a research note released on Wednesday morning, Benzinga reports. The...
StockNews.com Initiates Coverage on Akari Therapeutics (NASDAQ:AKTX)
Investment analysts at StockNews.com initiated coverage on shares of Akari Therapeutics (NASDAQ:AKTX – Get Free Report) in a research note issued on Thursday. The firm...
Chardan Capital Reiterates “Buy” Rating for Arrowhead Pharmaceuticals (NASDAQ:ARWR)
Chardan Capital restated their buy rating on shares of Arrowhead Pharmaceuticals (NASDAQ:ARWR – Free Report) in a research note issued to investors on Wednesday morning,...
Insider Selling: Nuvalent, Inc. (NASDAQ:NUVL) Director Sells 2,000 Shares of Stock
Nuvalent, Inc. (NASDAQ:NUVL – Get Free Report) Director Matthew Shair sold 2,000 shares of the firm’s stock in a transaction on Monday, June 24th. The...
Privia Health Group, Inc. (NASDAQ:PRVA) Receives $24.92 Average Price Target from Analysts
Privia Health Group, Inc. (NASDAQ:PRVA – Get Free Report) has earned an average rating of “Moderate Buy” from the fourteen research firms that are currently...